Literature DB >> 22096113

Impaired aerobic exercise adaptation in children and adolescents with craniopharyngioma is associated with hypothalamic involvement.

Xavier Piguel1, Pierre Abraham, Natacha Bouhours-Nouet, Frédérique Gatelais, Sylvie Dufresne, Stéphanie Rouleau, Régis Coutant.   

Abstract

OBJECTIVE: Many patients treated for craniopharyngioma (CP) complain of a relative incapacity for physical activity. Whether this is due to an objective decrease in adaptation to exercise is unclear. We assessed exercise tolerance in children with surgically treated CP and appropriate pituitary hormone replacement therapy compared with healthy controls and we examined the potential relationships with hypothalamic involvement, GH replacement, and the catecholamine deficiency frequently observed in these subjects. DESIGN AND METHODS: Seventeen subjects (12 males and five females) with CP and 22 healthy controls (14 males and eight females) aged 15.3±2.5 years (7.3-18 years) underwent a standardized cycle ergometer test. Maximum aerobic capacity was expressed as the ratio of VO(2max) to fat-free mass (VO(2max)/FFM), a measure independent of age and fat mass in children.
RESULTS: VO(2max)/FFM was 20% lower in children with CP compared with controls (P<0.05), even after adjustment for gender. Children with hypothalamic involvement (n=10) had a higher percentage of fat mass (P<0.05) than those without hypothalamic involvement (n=7) and lower VO(2max)/FFM (P<0.05), whereas children without hypothalamic involvement had VO(2max)/FFM close to that of controls (P>0.05). GH treatment was associated with a significant positive effect on aerobic capacity (P<0.05) only in the absence of hypothalamic involvement. No relationship was found between exercise capacity parameters and daily urine epinephrine excretion or epinephrine peak response to insulin-induced hypoglycemia.
CONCLUSIONS: Children with CP have a decrease in aerobic capacity mainly related to hypothalamic involvement. The hypothalamic factors altering aerobic capacity remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096113     DOI: 10.1530/EJE-11-0742

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

Review 1.  Management of craniopharyngiomas.

Authors:  N Karavitaki
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

2.  Cognitive Performance, Aerobic Fitness, Motor Proficiency, and Brain Function Among Children Newly Diagnosed With Craniopharyngioma.

Authors:  Heather M Conklin; Kirsten K Ness; Jason M Ashford; Matthew A Scoggins; Robert J Ogg; Yuanyuan Han; Yimei Li; Julie A Bradley; Frederick A Boop; Thomas E Merchant
Journal:  J Int Neuropsychol Soc       Date:  2019-04       Impact factor: 2.892

3.  Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up.

Authors:  Robyn E Partin; Matthew D Wogksch; Rikeenkumar Dhaduk; Jason M Ashford; Daniel J Indelicato; Heather M Conklin; Thomas E Merchant; Kirsten K Ness
Journal:  J Neurooncol       Date:  2022-08-20       Impact factor: 4.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.